Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A summary on the genetics of Systemic Lupus erythematosus, rheumatoid arthritis, systemic sclerosis, and Sjögren’s syndrome

  • Ortiz-Fernández, Lourdes
  • Martín, Javier
  • Alarcón-Riquelme, M. E.
Systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and Sjögren’s syndrome are four major autoimmune rheumatic diseases characterized by the presence of autoantibodies, caused by a dysregulation of the immune system that leads to a wide variety of clinical manifestations. These conditions present complex etiologies strongly influenced by multiple environmental and genetic factors. The human leukocyte antigen (HLA) region was the first locus identified to be associated and still represents the strongest susceptibility factor for each of these conditions, particularly the HLA class II genes, including DQA1, DQB1, and DRB1, but class I genes have also been associated. Over the last two decades, the genetic component of these disorders has been extensively investigated and hundreds of non-HLA risk genetic variants have been uncovered. Furthermore, it is widely accepted that autoimmune rheumatic diseases share molecular disease pathways, such as the interferon (IFN) type I pathways, which are reflected in a common genetic background. Some examples of well-known pleiotropic loci for autoimmune rheumatic diseases are the HLA region, DNASEL13, TNIP1, and IRF5, among others. The identification of the causal molecular mechanisms behind the genetic associations is still a challenge. However, recent advances have been achieved through mouse models and functional studies of the loci. Here, we provide an updated overview of the genetic architecture underlying these four autoimmune rheumatic diseases, with a special focus on the HLA region., This work was supported by the Spanish Ministry of Science and Innovation RTI2018-101332-B-100 to JM and PID2020-113776 Gb-I00 to MEAR), Red de Investigación en Inflamación y Enfermedades Reumáticas (RIER) from Instituto de Salud Carlos III (RD16/0012/0013 to JM), the Consejería de Salud y Familias (PE-0297–2019 to MEAR), and the Consejería de Transformación económica, industria, conocimiento y universidades (PY20-00473 to MEAR). LOF was funded by the Spanish Ministry of Science and Innovation through the Juan de la Cierva Incorporacion program (ref. IJC2019-040746-I)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

  • López-Isac, E.
  • Acosta-Herrera, M.
  • Kerick, M.
  • Assassi, S.
  • Satpathy, A.T.
  • Granja, J.
  • Mumbach, M.R.
  • Beretta, L.
  • Simeón, C.P.
  • Carreira, P.
  • Ortego-Centeno, N.
  • Castellvi, I.
  • Bossini-Castillo, L.
  • Carmona, F.D.
  • Orozco, G.
  • Hunzelmann, N.
  • Distler, J.H.W.
  • Franke, A.
  • Lunardi, C.
  • Moroncini, G.
  • Gabrielli, A.
  • de Vries-Bouwstra, J.
  • Wijmenga, C.
  • Koeleman, B.P.C.
  • Nordin, A.
  • Padyukov, L.
  • Hoffmann-Vold, A.-M.
  • Lie, B.
  • Ríos, R.
  • Callejas, J.L.
  • Vargas-Hitos, J.A.
  • García-Portales, R.
  • Camps, M.T.
  • Fernández-Nebro, A.
  • González-Escribano, M.F.
  • García-Hernández, F.J.
  • Castillo, M.J.
  • Aguirre, M.A.
  • Gómez-Gracia, I.
  • Fernández-Gutiérrez, B.
  • Rodríguez-Rodríguez, L.
  • García de la Peña, P.
  • Vicente, E.
  • Andreu, J.L.
  • Fernández de Castro, M.
  • López-Longo, F.J.
  • Martínez, L.
  • Fonollosa, V.
  • Guillén, A.
  • Espinosa, G.
  • Tolosa, C.
  • Pros, A.
  • Rodríguez-Carballeira, M.
  • Narváez, F.J.
  • Rubio-Rivas, M.
  • Ortiz-Santamaría, V
  • Madroñero, A.B.
  • González-Gay, M.A.
  • Díaz, B.
  • Trapiella, L.
  • Sousa, A.
  • Egurbide, M.V.
  • Fanlo-Mateo, P.
  • Sáez-Comet, L.
  • Díaz, F.
  • Hernández, V
  • Beltrán, E.
  • Román-Ivorra, J.A.
  • Grau E.
  • Alegre-Sancho, J.J.
  • Freire, M.
  • Blanco-García, F.J.
  • Oreiro, N.
  • Witte, T.
  • Kreuter, A.
  • Riemekasten, G.
  • Airó P.
  • Magro, C.
  • Voskuyl, A.E.
  • Vonk, M.C.
  • Hesselstrand, R.
  • Proudman S.
  • Stevens, W.
  • Nikpour, M.
  • Zochling, J.
  • Sahhar, J.
  • Roddy, J.
  • Nash, P.
  • Tymms, K.
  • Rischmueller, M.
  • Lester, S.
  • Vyse, T.
  • Herrick, A.L.
  • Worthington, J.
  • Denton C.P.
  • Allanore, Y.
  • Brown, M.A.
  • Radstake, T.R.D.J.
  • Fonseca, C.
  • Chang H.Y.
  • Mayes, M.D.
  • Martin, J.
  • European Scleroderma Group
  • Australian Scleroderma Interest Group (ASIG)
Systemic sclerosis (SSc) is an autoimmune disease that shows one of the highest mortality rates among rheumatic diseases. We perform a large genome-wide association study (GWAS), and meta-analysis with previous GWASs, in 26, 679 individuals and identify 27 independent genome-wide associated signals, including 13 new risk loci. The novel associations nearly double the number of genome-wide hits reported for SSc thus far. We define 95% credible sets of less than 5 likely causal variants in 12 loci. Additionally, we identify specific SSc subtype-associated signals. Functional analysis of high-priority variants shows the potential function of SSc signals, with the identification of 43 robust target genes through HiChIP. Our results point towards molecular pathways potentially involved in vasculopathy and fibrosis, two main hallmarks in SSc, and highlight the spectrum of critical cell types for the disease. This work supports a better understanding of the genetic basis of SSc and provides directions for future functional experiments.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

  • González-Serna, D.
  • Ochoa, E.
  • López-Isac, E.
  • Julià, A.
  • Degenhardt, F.
  • Ortego-Centeno, N.
  • Radstake, T.R.D.J.
  • Franke, A.
  • Marsal, S.
  • Mayes, M.D.
  • Martín, J.
  • Márquez, A.
  • Assassi, S.
  • Zhou, X.
  • Tan, F.K.
  • Arnett, F.C.
  • Reveille, J.D.
  • Gorlova, O.
  • Chen, W.V.
  • Ying, J.
  • Gregersen, P.K.
  • Lee, A.T.
  • Voskuyl, A.E.
  • de Vries-Bouwstra, J.
  • Magro-Checa, C.
  • Broen, J.
  • Koeleman, B.P.C.
  • Simeón, C.P.
  • Fonollosa, V.
  • Guillén, A.
  • Carreira, P.
  • Castellví, I.
  • González-Gay, M.A.
  • Ríos, R.
  • Callejas-Rubio, J.L.
  • Vargas-Hitos, J.A.
  • García-Portales, R.
  • Camps, M.T.
  • Fernández-Nebro, A.
  • González-Escribano, M.F.
  • García-Hernández, F.J.
  • Castillo, M.J.
  • Aguirre, M.Á.
  • Gómez-Gracia, I.
  • Rodríguez-Rodríguez, L.
  • Fernández-Gutiérrez, B.
  • de la Peña, P.G.
  • Vicente, E.
  • Andreu, J.L.
  • Fernández de Castro, M.
  • López-Longo, F.J.
  • Martínez, L.
  • Espinosa, G.
  • Tolosa, C.
  • Pros, A.
  • Rodríguez-Carballeira, M.
  • Narváez, F.J.
  • Rubio-Rivas, M.
  • Ortiz-Santamaría, V.
  • Madroñero, A.B.
  • Díaz, B.
  • Trapiella, L.
  • Sousa, A.
  • Egurbide, M.V.
  • Fanlo-Mateo, P.
  • Sáez-Comet, L.
  • Díaz-González, F.
  • Hernández, V.
  • Beltrán, E.
  • Román-Ivorra, J.A.
  • Grau, E.
  • Alegre-Sancho, J.J.
  • Blanco-García, F.J.
  • Oreiro, N.
  • Freire, M.
  • Balsa, A.
  • Ortiz, A.M.
  • Hunzelmann, N.
  • Riemekasten, G.
  • Distler, J.H.W.
  • Witte, T.
  • Airó, P.
  • Beretta, L.
  • Santaniello, A.
  • Bellocchi, C.
  • Lunardi, C.
  • Moroncini, G.
  • Gabrielli, A.
  • Scleroderma, Genetic, Consortium
Genome-wide association studies (GWASs) have identified a number of genetic risk loci associated with systemic sclerosis (SSc) and Crohn’s disease (CD), some of which confer susceptibility to both diseases. In order to identify new risk loci shared between these two immune-mediated disorders, we performed a cross-disease meta-analysis including GWAS data from 5, 734 SSc patients, 4, 588 CD patients and 14, 568 controls of European origin. We identified 4 new loci shared between SSc and CD, IL12RB2, IRF1/SLC22A5, STAT3 and an intergenic locus at 6p21.31. Pleiotropic variants within these loci showed opposite allelic effects in the two analysed diseases and all of them showed a significant effect on gene expression. In addition, an enrichment in the IL-12 family and type I interferon signaling pathways was observed among the set of SSc-CD common genetic risk loci. In conclusion, through the first cross-disease meta-analysis of SSc and CD, we identified genetic variants with pleiotropic effects on two clinically distinct immune-mediated disorders. The fact that all these pleiotropic SNPs have opposite allelic effects in SSc and CD reveals the complexity of the molecular mechanisms by which polymorphisms affect diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci

  • Li, Tianlu|||0000-0001-7152-4870
  • Ortiz-Fernández, Lourdes|||0000-0002-0247-4280
  • Andrés-León, Eduardo|||0000-0002-0621-9914
  • Ciudad, Laura|||0000-0002-5219-6792
  • Javierre, B. M.|||0000-0002-8682-6748
  • López-Isac, E.
  • Guillén-Del-Castillo, A.
  • Simeón-Aznar, C. P.
  • Ballestar, Esteban|||0000-0002-1400-2440
  • Martín, Javier|||0000-0002-2202-0622
Background: Systemic sclerosis (SSc) is a genetically complex autoimmune disease mediated by the interplay between genetic and epigenetic factors in a multitude of immune cells, with CD4+ T lymphocytes as one of the principle drivers of pathogenesis. Methods: DNA samples exacted from CD4+ T cells of 48 SSc patients and 16 healthy controls were hybridized on MethylationEPIC BeadChip array. In parallel, gene expression was interrogated by hybridizing total RNA on Clariom™ S array. Downstream bioinformatics analyses were performed to identify correlating differentially methylated CpG positions (DMPs) and differentially expressed genes (DEGs), which were then confirmed utilizing previously published promoter capture Hi-C (PCHi-C) data. Results: We identified 9112 and 3929 DMPs and DEGs, respectively. These DMPs and DEGs are enriched in functional categories related to inflammation and T cell biology. Furthermore, correlation analysis identified 17,500 possible DMP-DEG interaction pairs within a window of 5 Mb, and utilizing PCHi-C data, we observed that 212 CD4+ T cell-specific pairs of DMP-DEG also formed part of three-dimensional promoter-enhancer networks, potentially involving CTCF. Finally, combining PCHi-C data with SSc GWAS data, we identified four important SSc-associated susceptibility loci, TNIP1 (rs3792783), GSDMB (rs9303277), IL12RB1 (rs2305743), and CSK (rs1378942), that could potentially interact with DMP-DEG pairs cg17239269-ANXA6, cg19458020-CCR7, cg10808810-JUND, and cg11062629-ULK3, respectively. Conclusion: Our study unveils a potential link between genetic, epigenetic, and transcriptional deregulation in CD4+ T cells of SSc patients, providing a novel integrated view of molecular components driving SSc pathogenesis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility

  • González-Serna, David
  • Carmona, Elio G.
  • Ortego-Centeno, Norberto|||0000-0003-2325-0937
  • Simeón-Aznar, Carmen Pilar|||0000-0003-3390-9029
  • Solans, Roser|||0000-0002-0058-1293
  • Hernández Rodríguez, José|||0000-0002-2357-2015
  • Tolosa, Carlos
  • Castañeda, Santos|||0000-0002-7748-853X
  • Narváez, Javier|||0000-0002-1614-8064
  • Martinez-Valle, Ferran
  • Witte, Torsten
  • Neumann, Thomas
  • Holle, Julia
  • Beretta, Lorenzo|||0000-0002-6529-6258
  • Boiardi, Luigi
  • Emmi, Giacomo|||0000-0001-9575-8321
  • Cimmino, Marco Amedeo|||0000-0002-6956-7860
  • Vaglio, Augusto
  • Herrick, Ariane|||0000-0003-4941-7926
  • Denton, Christopher P.
  • Salvarani, Carlo|||0000-0001-5426-5133
  • Cid, María Cinta|||0000-0002-4730-0938
  • Morgan, Ann W.
  • Fonseca, Carmen
  • Gonzalez-Gay, MA.|||0000-0002-7924-7406
  • Martín, Javier|||0000-0002-2202-0622
  • Márquez, Ana|||0000-0001-9913-7688
The TNFSF13B (TNF superfamily member 13b) gene encodes BAFF, a cytokine with a crucial role in the differentiation and activation of B cells. An insertion-deletion variant (GCTGT→A) of this gene, leading to increased levels of BAFF, has been recently implicated in the genetic predisposition to several autoimmune diseases, including multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Based on the elevated levels of this cytokine found in patients with giant cell arteritis (GCA) and systemic sclerosis (SSc), we aimed to assess whether this functional variant also represents a novel genetic risk factor for these two disorders. A total of 1,728 biopsy-proven GCA patients from 4 European cohorts, 4,584 SSc patients from 3 European cohorts and 5,160 ethnically-matched healthy controls were included in the study. The single nucleotide polymorphism (SNP) rs374039502, which colocalizes with the genetic variant previously implicated in autoimmunity, was genotyped using a custom TaqMan assay. First, association analysis was conducted in each independent cohort using χ2 test in Plink (v1.9). Subsequently, different case/control sets were meta-analyzed by the inverse variance method. No statistically significant differences were found when allele distributions were compared between cases and controls for any of the analyzed cohorts. Similarly, combined analysis of the different sets evidenced a lack of association of the rs374039502 variant with GCA (P = 0.421; OR (95% CI) = 0.92 (0.75-1.13)) and SSc (P = 0.500; OR (95% CI) = 1.05 (0.91-1.22)). The stratified analysis considering the main clinical subphenotypes of these diseases yielded similar negative results. Our data suggest that the TNFSF13B functional variant does not contribute to the genetic network underlying GCA and SSc.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The synovial and blood monocyte DNA methylomes mirror prognosis, evolution, and treatment in early arthritis

  • de la Calle-Fabregat, Carlos|||0000-0002-3026-3069
  • Rodríguez-Ubreva, Javier|||0000-0003-4707-4536
  • Ciudad, Laura|||0000-0002-5219-6792
  • Ramírez, Julio
  • Celis, Raquel|||0000-0002-5096-4532
  • Azuaga, Ana Belén
  • Cuervo, Andrea
  • Graell, Eduard|||0000-0002-4210-2721
  • Pérez-García, Carolina|||0000-0002-6695-6406
  • Diaz-Torne, Cesar|||0000-0001-6275-7699
  • Salvador, Georgina
  • Gómez-Puerta, Jose A.|||0000-0001-8177-702X
  • Haro, Isabel|||0000-0001-8677-2340
  • Sanmartí, Raimon|||0000-0002-8864-3806
  • Cañete, Juan D.|||0000-0003-2606-0573
  • Ballestar, Esteban|||0000-0002-1400-2440
Identifying predictive biomarkers at early stages of inflammatory arthritis is crucial for starting appropriate therapies to avoid poor outcomes. Monocytes (MOs) and macrophages, largely associated with arthritis, are contributors and sensors of inflammation through epigenetic modifications. In this study, we investigated associations between clinical features and DNA methylation in blood and synovial fluid (SF) MOs in a prospective cohort of patients with early inflammatory arthritis. DNA methylation profiles of undifferentiated arthritis (UA) blood MOs exhibited marked alterations in comparison with those from healthy donors. We identified additional differences both in blood and SF MOs after comparing patients with UA grouped by their future outcomes, i.e., good versus poor. Patient profiles in subsequent visits revealed a reversion toward a healthy level in both groups, those requiring disease-modifying antirheumatic drugs and those who remitted spontaneously. Changes in disease activity between visits also affected DNA methylation, which was partially concomitant in the SF of UA and in blood MOs of patients with rheumatoid arthritis. Epigenetic similarities between arthritis types allow a common prediction of disease activity. Our results constitute a resource of DNA methylation-based biomarkers of poor prognosis, disease activity, and treatment efficacy for the personalized clinical management of early inflammatory arthritis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Methylome and transcriptome profiling of giant cell arteritis monocytes reveals novel pathways involved in disease pathogenesis and molecular response to glucocorticoids

  • Estupiñán-Moreno, Elkyn|||0000-0002-5818-4389
  • Ortiz-Fernández, Lourdes|||0000-0002-0247-4280
  • Li, Tianlu|||0000-0001-7152-4870
  • Hernández Rodríguez, José|||0000-0002-2357-2015
  • Ciudad, Laura|||0000-0002-5219-6792
  • Andrés-León, Eduardo|||0000-0002-0621-9914
  • Terron-Camero, Laura Carmen
  • Prieto-González, Sergio|||0000-0003-3179-597X
  • Espígol Frigolé, Georgina|||0000-0002-8299-0209
  • Cid, María Cinta|||0000-0002-4730-0938
  • Márquez, Ana|||0000-0001-9913-7688
  • Ballestar, Esteban|||0000-0002-1400-2440
  • Martín, Javier|||0000-0002-2202-0622
Objectives Giant cell arteritis (GCA) is a complex systemic vasculitis mediated by the interplay between both genetic and epigenetic factors. Monocytes are crucial players of the inflammation occurring in GCA. Therefore, characterisation of the monocyte methylome and transcriptome in GCA would be helpful to better understand disease pathogenesis. Methods We performed an integrated epigenome-and transcriptome-wide association study in CD14+ monocytes from 82 patients with GCA, cross-sectionally classified into three different clinical statuses (active, in remission with or without glucocorticoid (GC) treatment), and 31 healthy controls. Results We identified a global methylation and gene expression dysregulation in GCA monocytes. Specifically, monocytes from active patients showed a more proinflammatory phenotype compared with healthy controls and patients in remission. In addition to inflammatory pathways known to be involved in active GCA, such as response to IL-6 and IL-1, we identified response to IL-11 as a new pathway potentially implicated in GCA. Furthermore, monocytes from patients in remission with treatment showed downregulation of genes involved in inflammatory processes as well as overexpression of GC receptor-target genes. Finally, we identified changes in DNA methylation correlating with alterations in expression levels of genes with a potential role in GCA pathogenesis, such as ITGA7 and CD63, as well as genes mediating the molecular response to GC, including FKBP5, ETS2, ZBTB16 and ADAMTS2. Conclusion Our results revealed profound alterations in the methylation and transcriptomic profiles of monocytes from GCA patients, uncovering novel genes and pathways involved in GCA pathogenesis and in the molecular response to GC treatment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

  • Kerick, Martin|||0000-0002-6298-4514
  • Acosta-Herrera, Marialbert|||0000-0002-9868-6535
  • Simeón-Aznar, Carmen Pilar|||0000-0003-3390-9029
  • Callejas Rubio, Jose Luis|||0000-0002-1653-0087
  • Assassi, Shervin|||0000-0002-8059-9978
  • Carreira, Patricia E.|||0000-0001-8279-3806
  • Castellvi, Ivan|||0000-0002-5410-5807
  • Ríos, Raquel
  • García-Portales, Rosa
  • Fernández-Nebro, Antonio|||0000-0002-2962-9844
  • García-Hernández, Francisco Jose|||0000-0002-2600-0485
  • Aguirre, Mª Angeles|||0000-0002-5653-4293
  • Fernández-Gutiérrez, Benjamín
  • Rodriguez-Rodriguez, Luis|||0000-0002-2869-7861
  • García de la Peña-Lefebvre, Paloma
  • Vicente-Rabaneda, Esther Francisca
  • Andréu, José Luis|||0000-0002-6002-1239
  • Fernández de Castro, Mónica
  • López Longo, Francisco Javier
  • Fonollosa Pla, Vicent
  • Guillén-Del-Castillo, Alfredo|||0000-0003-0626-507X
  • Espinosa, Gerard|||0000-0003-1336-0163
  • Tolosa, Carlos
  • Pros, Ana|||0000-0003-0266-0531
  • Beltran Catalan, Emma|||0000-0001-8070-6916
  • Rodríguez-Carballeira, Mónica|||0000-0002-8802-0238
  • Narváez, Javier|||0000-0002-1614-8064
  • Rubio Rivas, Manuel|||0000-0002-9548-1374
  • Ortiz-Santamaría, Vera
  • Madroñero, Ana Belén
  • Gonzalez-Gay, MA.|||0000-0002-7924-7406
  • Díaz, Bernardino
  • Trapiella, Luis
  • Egurbide, María Victoria
  • Fanlo-Mateo, Patricia
  • Sáez-Comet, Luis|||0000-0002-9868-6498
  • Díaz, F.
  • Román-Ivorra, José Andrés
  • Alegre-Sancho, Juan José|||0000-0003-1641-0875
  • Freire, Mercedes
  • Garcia, Francisco J.B.
  • Oreiro, Natividad
  • Witte, Torsten
  • Kreuter, Alexander|||0000-0003-2275-499X
  • Riemekasten, Gabriela
  • Airò, Paolo
  • Magro-Checa, César
  • Voskuyl, A.E.|||0000-0002-9699-1827
  • Vonk, Madelon C.
  • Hesselstrand, Roger
  • Nordin, Annika|||0000-0003-1976-4679
  • Lunardi, Claudio|||0000-0001-6446-2990
  • Gabrielli, Armando
  • Hoffmann-Vold, A.
  • Distler, J.H.W.
  • Padyukov, Leonid|||0000-0003-2950-5670
  • Koeleman, B.P.C.
  • Proudman, Susanna M.
  • Nikpour, Mandana
  • Stevens, W.
  • Zochling, Jane M.
  • Sahhar, Joanne|||0000-0003-4220-2906
  • Roddy, J.
  • Nash, P.
  • Tymms, Kathleen
  • Rischmueller, Maureen
  • Lester, Susan Elizabeth
  • Vigone, Barbara
  • Pers, Jacques-Olivier|||0000-0001-7287-5541
  • Saraux, Alain
  • Devauchelle-Pensec, Valérie
  • Cornec, Divi|||0000-0002-9159-702X
  • Jousse-Joulin, Sandrine
  • Lauwerys, Bernard
  • Ducreux, Julie
  • Maudoux, Anne-Lise
  • Vasconcelos, Carlos
  • Tavares, Ana
  • Neves, Esmeralda
  • Faria, Raquel
  • Brandão, Mariana
  • Campar, Ana
  • Marinho, António
  • Farinha, Fátima
  • Almeida, Isabel
  • Blanco, Ricardo|||0000-0003-2344-2285
  • Corrales Martínez, Alfonso
  • Cervera, Ricard
  • Rodríguez-Pintó, Ignasi
  • Lories, Rik
  • De Langhe, Ellen|||0000-0002-4045-2146
  • Belz, Doreen
  • Baerlecken, Niklas
  • Stummvoll, Georg
  • Zauner, Michael
  • Lehner, Michaela
  • Collantes Estevéz, Eduardo|||0000-0002-7647-6289
  • Ortega Castro, Rafaela|||0000-0002-7552-3469
  • Escudero Contreras, Alejandro|||0000-0001-5891-5527
  • Castro-Villegas, Ma Carmen
  • Fernández Roldán, María Concepción
  • Ortego-Centeno, Norberto|||0000-0003-2325-0937
  • Raya, Enrique
  • Jiménez Moleón, Inmaculada
  • de Ramon, Enrique
  • Díaz Quintero, Isabel
  • Meroni, Pier Luigi|||0000-0002-3394-1451
  • Gerosa, Maria|||0000-0001-5241-5847
  • Schioppo, Tommaso|||0000-0001-8359-5131
  • Artusi, Carolina
  • Chizzolini, Carlo
  • Zuber, Aleksandra
  • Wynar, Donatienne
  • Kovács, Laszló
  • Balog, Attila
  • Deák, Magdolna
  • Bocskai, Márta
  • Dulic, Sonja
  • Kádár, Gabriella
  • Hiepe, Falk|||0000-0003-3584-5292
  • Gerl, Velia
  • Thiel, Silvia
  • rodriguez Maresca, Manuel
  • López-Berrio, Antonio
  • Aguilar-Quesada, Rocío|||0000-0003-3125-6634
  • Navarro-Linares, Héctor
  • Hunzelmann, Nicolas
  • Moroncini, Gianluca|||0000-0002-0380-0105
  • de Vries-Bouwstra, Jeska K.
  • Orozco, Gisela|||0000-0002-3479-0448
  • Barton, Anne|||0000-0003-3316-2527
  • Herrick, Ariane|||0000-0003-4941-7926
  • Terao, Chikashi|||0000-0002-6452-4095
  • Allanore, Yannick|||0000-0002-6149-0002
  • Fonseca, Carmen
  • Alarcón-Riquelme, Marta E.|||0000-0002-7632-4154
  • Radstake, Timothy R.D.J.
  • Beretta, Lorenzo|||0000-0002-6529-6258
  • Denton, Christopher P.
  • Mayes, Maureen D.|||0000-0001-5070-2535
  • Martín, Javier|||0000-0002-2202-0622
Copy number (CN) polymorphisms of complement C4 play distinct roles in many conditions, including immune-mediated diseases. We investigated the association of C4 CN with systemic sclerosis (SSc) risk. Imputed total C4, C4A, C4B, and HERV-K CN were analyzed in 26,633 individuals and validated in an independent cohort. Our results showed that higher C4 CN confers protection to SSc, and deviations from CN parity of C4A and C4B augmented risk. The protection contributed per copy of C4A and C4B differed by sex. Stronger protection was afforded by C4A in men and by C4B in women. C4 CN correlated well with its gene expression and serum protein levels, and less C4 was detected for both in SSc patients. Conditioned analysis suggests that C4 genetics strongly contributes to the SSc association within the major histocompatibility complex locus and highlights classical alleles and amino acid variants of HLA-DRB1 and HLA-DPB1 as C4-independent signals.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

  • López-Isac, Elena|||0000-0001-8806-5148
  • Acosta-Herrera, Marialbert|||0000-0002-9868-6535
  • Kerick, Martin|||0000-0002-6298-4514
  • Assassi, Shervin|||0000-0002-8059-9978
  • Satpathy, Ansuman|||0000-0002-5167-537X
  • Granja, Jeffrey
  • Mumbach, Maxwell|||0000-0002-5570-6663
  • Beretta, Lorenzo|||0000-0002-6529-6258
  • Simeón-Aznar, Carmen Pilar|||0000-0003-3390-9029
  • Carreira, Patricia E.|||0000-0001-8279-3806
  • Ortego-Centeno, Norberto|||0000-0003-2325-0937
  • Castellvi, Ivan|||0000-0002-5410-5807
  • Bossini-Castillo, Lara|||0000-0002-5471-5824
  • Carmona, F. David|||0000-0002-1427-7639
  • Orozco, Gisela|||0000-0002-3479-0448
  • Hunzelmann, Nicolas
  • Distler, Jörg|||0000-0001-7408-9333
  • Franke, Andre|||0000-0003-1530-5811
  • Lunardi, Claudio|||0000-0001-6446-2990
  • Moroncini, Gianluca|||0000-0002-0380-0105
  • Gabrielli, Armando
  • de Vries-Bouwstra, Jeska
  • Wijmenga, Cisca|||0000-0002-5635-1614
  • Koeleman, Bobby|||0000-0001-7749-182X
  • Nordin, Annika|||0000-0003-1976-4679
  • Padyukov, Leonid|||0000-0003-2950-5670
  • Hoffmann-Vold, A.M.|||0000-0001-6467-7422
  • Lie, Benedicte A.|||0000-0002-1159-7004
  • Ríos, Raquel
  • Callejas Rubio, Jose Luis|||0000-0002-1653-0087
  • Vargas-Hitos, José Antonio|||0000-0002-0596-8710
  • García-Portales, Rosa
  • Camps, María Teresa
  • Fernández-Nebro, Antonio|||0000-0002-2962-9844
  • González-Escribano, Maria Francisca
  • García-Hernández, Francisco Jose|||0000-0002-2600-0485
  • Castillo, María Jesús
  • Aguirre, Mª Angeles|||0000-0002-5653-4293
  • Gómez-Gracia, Inmaculada
  • Fernández-Gutiérrez, B.|||0000-0002-6126-8786
  • Rodríguez-Rodríguez, L.
  • García de la Peña, Paloma|||0000-0001-6586-6903
  • Vicente-Rabaneda, Esther Francisca
  • Andréu, José Luis|||0000-0002-6002-1239
  • Fernández de Castro, Mónica
  • López Longo, Francisco Javier
  • Martínez, Lina
  • Fonollosa, Vicenç
  • Guillén, Alfredo Chávez
  • Espinosa, Gerard|||0000-0003-1336-0163
  • Tolosa Vilella, Carles|||0000-0002-3379-4412
  • Pros, Ana|||0000-0003-0266-0531
  • Rodríguez-Carballeira, M.
  • Narváez, Francisco J.
  • Rubio Rivas, Manuel|||0000-0002-9548-1374
  • Ortiz-Santamaría, None
  • Madroñero, A.B.
  • Gonzalez-Gay, MA.|||0000-0002-7924-7406
  • Díaz, Bernardino
  • Trapiella, L.
  • Sousa, A.
  • Egurbide, María Victoria
  • Fanlo-Mateo, P.
  • Sáez-Comet, Luis|||0000-0002-9868-6498
  • Díaz, F.
  • Hernández, None
  • Beltrán, E.
  • Román-Ivorra, J.A.
  • Grau, E.
  • Alegre-Sancho, Juan José|||0000-0003-1641-0875
  • Freire, M.
  • Blanco-García, F.J.|||0000-0001-9821-7635
  • Oreiro, N.
  • Witte, Torsten
  • Kreuter, A.
  • Riemekasten, G.|||0000-0002-5406-2464
  • Airò, Paolo
  • Magro-Checa, César
  • Voskuyl, A.E.|||0000-0002-9699-1827
  • Vonk, Madelon C.
  • Hesselstrand, Roger
  • Proudman, Susanna
  • Stevens, Wendy
  • Nikpour, Mandana
  • Zochling, Jane M.
  • Sahhar, Joanne|||0000-0003-4220-2906
  • Roddy, Janet
  • Nash, Peter
  • Tymms, Kathleen
  • Rischmueller, Maureen
  • Lester, S.
  • Vyse, Timothy|||0000-0003-1123-1464
  • Herrick, Ariane|||0000-0003-4941-7926
  • Worthington, Jane
  • Denton, Christopher P.
  • Allanore, Yannick|||0000-0002-6149-0002
  • Brown, Matthew A.|||0000-0003-0538-8211
  • Radstake, Timothy R. D. J.
  • Fonseca, Carmen
  • Chang, Howard Y.
  • Mayes, Maureen D.|||0000-0001-5070-2535
  • Martín, Javier|||0000-0002-2202-0622
Systemic sclerosis (SSc) is an autoimmune disease that shows one of the highest mortality rates among rheumatic diseases. We perform a large genome-wide association study (GWAS), and meta-analysis with previous GWASs, in 26,679 individuals and identify 27 independent genome-wide associated signals, including 13 new risk loci. The novel associations nearly double the number of genome-wide hits reported for SSc thus far. We define 95% credible sets of less than 5 likely causal variants in 12 loci. Additionally, we identify specific SSc subtype-associated signals. Functional analysis of high-priority variants shows the potential function of SSc signals, with the identification of 43 robust target genes through HiChIP. Our results point towards molecular pathways potentially involved in vasculopathy and fibrosis, two main hallmarks in SSc, and highlight the spectrum of critical cell types for the disease. This work supports a better understanding of the genetic basis of SSc and provides directions for future functional experiments.